Go Pro

Integra LifeSciences (IART) Competitors

Integra LifeSciences logo
$16.65 0.00 (0.00%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$16.64 0.00 (-0.03%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

IART vs. TFX, ITGR, SMA, ATRC, and ATEC

Should you buy Integra LifeSciences stock or one of its competitors? MarketBeat compares Integra LifeSciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Integra LifeSciences include Teleflex (TFX), Integer (ITGR), Smartstop Self Storage REIT (SMA), AtriCure (ATRC), and Alphatec (ATEC).

How does Integra LifeSciences compare to Teleflex?

Integra LifeSciences (NASDAQ:IART) and Teleflex (NYSE:TFX) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, media sentiment, valuation, institutional ownership, analyst recommendations, risk and dividends.

Integra LifeSciences has a net margin of -0.44% compared to Teleflex's net margin of -35.88%. Integra LifeSciences' return on equity of 18.30% beat Teleflex's return on equity.

Company Net Margins Return on Equity Return on Assets
Integra LifeSciences-0.44% 18.30% 5.30%
Teleflex -35.88%13.29%6.55%

Integra LifeSciences currently has a consensus price target of $18.86, suggesting a potential upside of 13.26%. Teleflex has a consensus price target of $148.90, suggesting a potential upside of 8.91%. Given Integra LifeSciences' higher possible upside, research analysts clearly believe Integra LifeSciences is more favorable than Teleflex.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integra LifeSciences
2 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.88
Teleflex
1 Sell rating(s)
6 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.42

In the previous week, Integra LifeSciences had 16 more articles in the media than Teleflex. MarketBeat recorded 29 mentions for Integra LifeSciences and 13 mentions for Teleflex. Teleflex's average media sentiment score of 1.06 beat Integra LifeSciences' score of 0.61 indicating that Teleflex is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Integra LifeSciences
8 Very Positive mention(s)
3 Positive mention(s)
12 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Teleflex
8 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Integra LifeSciences has a beta of 1.22, suggesting that its stock price is 22% more volatile than the broader market. Comparatively, Teleflex has a beta of 0.81, suggesting that its stock price is 19% less volatile than the broader market.

84.8% of Integra LifeSciences shares are owned by institutional investors. Comparatively, 95.6% of Teleflex shares are owned by institutional investors. 3.8% of Integra LifeSciences shares are owned by company insiders. Comparatively, 0.7% of Teleflex shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Integra LifeSciences has higher earnings, but lower revenue than Teleflex. Integra LifeSciences is trading at a lower price-to-earnings ratio than Teleflex, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Integra LifeSciences$1.65B0.79-$516.47M-$0.09N/A
Teleflex$1.99B3.04-$905.64M-$22.80N/A

Summary

Teleflex beats Integra LifeSciences on 9 of the 17 factors compared between the two stocks.

How does Integra LifeSciences compare to Integer?

Integer (NYSE:ITGR) and Integra LifeSciences (NASDAQ:IART) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, media sentiment, dividends, analyst recommendations, institutional ownership and profitability.

99.3% of Integer shares are held by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are held by institutional investors. 1.1% of Integer shares are held by company insiders. Comparatively, 3.8% of Integra LifeSciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Integer has higher revenue and earnings than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Integer$1.85B2.22$102.81M$4.0130.19
Integra LifeSciences$1.65B0.79-$516.47M-$0.09N/A

Integer currently has a consensus target price of $97.00, suggesting a potential downside of 19.88%. Integra LifeSciences has a consensus target price of $18.86, suggesting a potential upside of 13.26%. Given Integra LifeSciences' higher possible upside, analysts plainly believe Integra LifeSciences is more favorable than Integer.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integer
0 Sell rating(s)
7 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.54
Integra LifeSciences
2 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.88

Integer has a net margin of 7.64% compared to Integra LifeSciences' net margin of -0.44%. Integra LifeSciences' return on equity of 18.30% beat Integer's return on equity.

Company Net Margins Return on Equity Return on Assets
Integer7.64% 12.83% 6.51%
Integra LifeSciences -0.44%18.30%5.30%

In the previous week, Integra LifeSciences had 8 more articles in the media than Integer. MarketBeat recorded 29 mentions for Integra LifeSciences and 21 mentions for Integer. Integer's average media sentiment score of 0.81 beat Integra LifeSciences' score of 0.61 indicating that Integer is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Integer
10 Very Positive mention(s)
1 Positive mention(s)
9 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Integra LifeSciences
8 Very Positive mention(s)
3 Positive mention(s)
12 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Integer has a beta of 0.61, indicating that its stock price is 39% less volatile than the broader market. Comparatively, Integra LifeSciences has a beta of 1.22, indicating that its stock price is 22% more volatile than the broader market.

Summary

Integer beats Integra LifeSciences on 12 of the 17 factors compared between the two stocks.

How does Integra LifeSciences compare to Smartstop Self Storage REIT?

Smartstop Self Storage REIT (NYSE:SMA) and Integra LifeSciences (NASDAQ:IART) are related small-cap companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, media sentiment, earnings and risk.

Smartstop Self Storage REIT has higher earnings, but lower revenue than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than Smartstop Self Storage REIT, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Smartstop Self Storage REIT$281.14M6.61-$1.55M$0.15223.77
Integra LifeSciences$1.65B0.79-$516.47M-$0.09N/A

Smartstop Self Storage REIT has a net margin of 4.38% compared to Integra LifeSciences' net margin of -0.44%. Integra LifeSciences' return on equity of 18.30% beat Smartstop Self Storage REIT's return on equity.

Company Net Margins Return on Equity Return on Assets
Smartstop Self Storage REIT4.38% 1.00% 0.54%
Integra LifeSciences -0.44%18.30%5.30%

Smartstop Self Storage REIT has a beta of 0.5, suggesting that its share price is 50% less volatile than the broader market. Comparatively, Integra LifeSciences has a beta of 1.22, suggesting that its share price is 22% more volatile than the broader market.

In the previous week, Integra LifeSciences had 25 more articles in the media than Smartstop Self Storage REIT. MarketBeat recorded 29 mentions for Integra LifeSciences and 4 mentions for Smartstop Self Storage REIT. Smartstop Self Storage REIT's average media sentiment score of 1.41 beat Integra LifeSciences' score of 0.61 indicating that Smartstop Self Storage REIT is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Smartstop Self Storage REIT
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Integra LifeSciences
8 Very Positive mention(s)
3 Positive mention(s)
12 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Smartstop Self Storage REIT currently has a consensus target price of $36.44, suggesting a potential upside of 8.56%. Integra LifeSciences has a consensus target price of $18.86, suggesting a potential upside of 13.26%. Given Integra LifeSciences' higher probable upside, analysts clearly believe Integra LifeSciences is more favorable than Smartstop Self Storage REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Smartstop Self Storage REIT
1 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
2 Strong Buy rating(s)
2.70
Integra LifeSciences
2 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.88

84.8% of Integra LifeSciences shares are owned by institutional investors. 5.7% of Smartstop Self Storage REIT shares are owned by insiders. Comparatively, 3.8% of Integra LifeSciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Smartstop Self Storage REIT beats Integra LifeSciences on 10 of the 17 factors compared between the two stocks.

How does Integra LifeSciences compare to AtriCure?

Integra LifeSciences (NASDAQ:IART) and AtriCure (NASDAQ:ATRC) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, dividends, valuation, profitability and institutional ownership.

AtriCure has a net margin of 1.85% compared to Integra LifeSciences' net margin of -0.44%. Integra LifeSciences' return on equity of 18.30% beat AtriCure's return on equity.

Company Net Margins Return on Equity Return on Assets
Integra LifeSciences-0.44% 18.30% 5.30%
AtriCure 1.85%2.34%1.77%

In the previous week, Integra LifeSciences had 9 more articles in the media than AtriCure. MarketBeat recorded 29 mentions for Integra LifeSciences and 20 mentions for AtriCure. Integra LifeSciences' average media sentiment score of 0.61 beat AtriCure's score of 0.41 indicating that Integra LifeSciences is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Integra LifeSciences
8 Very Positive mention(s)
3 Positive mention(s)
12 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
AtriCure
8 Very Positive mention(s)
2 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Integra LifeSciences has a beta of 1.22, indicating that its share price is 22% more volatile than the broader market. Comparatively, AtriCure has a beta of 1.2, indicating that its share price is 20% more volatile than the broader market.

Integra LifeSciences currently has a consensus price target of $18.86, suggesting a potential upside of 13.26%. AtriCure has a consensus price target of $48.50, suggesting a potential upside of 28.44%. Given AtriCure's stronger consensus rating and higher probable upside, analysts plainly believe AtriCure is more favorable than Integra LifeSciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integra LifeSciences
2 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.88
AtriCure
1 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
2.82

84.8% of Integra LifeSciences shares are held by institutional investors. Comparatively, 99.1% of AtriCure shares are held by institutional investors. 3.8% of Integra LifeSciences shares are held by company insiders. Comparatively, 4.0% of AtriCure shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

AtriCure has lower revenue, but higher earnings than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than AtriCure, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Integra LifeSciences$1.65B0.79-$516.47M-$0.09N/A
AtriCure$534.53M3.59-$11.45M$0.21179.81

Summary

AtriCure beats Integra LifeSciences on 11 of the 17 factors compared between the two stocks.

How does Integra LifeSciences compare to Alphatec?

Alphatec (NASDAQ:ATEC) and Integra LifeSciences (NASDAQ:IART) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and media sentiment.

Alphatec presently has a consensus target price of $17.13, suggesting a potential upside of 79.97%. Integra LifeSciences has a consensus target price of $18.86, suggesting a potential upside of 13.26%. Given Alphatec's stronger consensus rating and higher probable upside, equities research analysts clearly believe Alphatec is more favorable than Integra LifeSciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alphatec
1 Sell rating(s)
1 Hold rating(s)
12 Buy rating(s)
1 Strong Buy rating(s)
2.87
Integra LifeSciences
2 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.88

Alphatec has higher earnings, but lower revenue than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than Alphatec, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alphatec$764.16M1.92-$143.36M-$0.82N/A
Integra LifeSciences$1.65B0.79-$516.47M-$0.09N/A

Alphatec has a beta of 0.85, meaning that its share price is 15% less volatile than the broader market. Comparatively, Integra LifeSciences has a beta of 1.22, meaning that its share price is 22% more volatile than the broader market.

66.4% of Alphatec shares are held by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are held by institutional investors. 13.5% of Alphatec shares are held by company insiders. Comparatively, 3.8% of Integra LifeSciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Integra LifeSciences has a net margin of -0.44% compared to Alphatec's net margin of -15.93%. Integra LifeSciences' return on equity of 18.30% beat Alphatec's return on equity.

Company Net Margins Return on Equity Return on Assets
Alphatec-15.93% -1,183.84% -15.83%
Integra LifeSciences -0.44%18.30%5.30%

In the previous week, Integra LifeSciences had 18 more articles in the media than Alphatec. MarketBeat recorded 29 mentions for Integra LifeSciences and 11 mentions for Alphatec. Integra LifeSciences' average media sentiment score of 0.61 beat Alphatec's score of 0.50 indicating that Integra LifeSciences is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alphatec
4 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Integra LifeSciences
8 Very Positive mention(s)
3 Positive mention(s)
12 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Integra LifeSciences beats Alphatec on 9 of the 17 factors compared between the two stocks.

Get Integra LifeSciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for IART and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IART and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IART vs. The Competition

MetricIntegra LifeSciencesHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$1.29B$5.58B$6.85B$12.42B
Dividend YieldN/A1.79%2.59%10.03%
P/E Ratio-184.9823.11282.3024.66
Price / Sales0.7956.86563.1275.93
Price / Cash3.9432.5328.6046.71
Price / Book1.246.2910.966.07
Net Income-$516.47M$151.15M$3.49B$347.99M
7 Day Performance-14.75%0.98%-0.64%-0.44%
1 Month Performance-7.76%-3.48%-5.23%-4.81%
1 Year Performance35.26%2.34%61.97%18.61%

Integra LifeSciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IART
Integra LifeSciences
2.1216 of 5 stars
$16.65
flat
$18.86
+13.3%
+35.3%$1.29B$1.65BN/A4,427
TFX
Teleflex
3.0025 of 5 stars
$133.97
+2.2%
$147.70
+10.2%
+18.0%$5.92B$2.13BN/A15,500
ITGR
Integer
2.2092 of 5 stars
$100.54
+1.1%
$97.00
-3.5%
+13.7%$3.41B$1.85B25.0411,000
SMA
Smartstop Self Storage REIT
3.3349 of 5 stars
$35.71
+1.7%
$36.44
+2.0%
-3.5%$1.98B$294.00M238.08N/A
ATRC
AtriCure
4.106 of 5 stars
$38.27
+2.4%
$48.50
+26.7%
+9.7%$1.94B$534.53M182.411,300

Related Companies and Tools


This page (NASDAQ:IART) was last updated on 8/3/2026 by MarketBeat.com Staff.
From Our Partners